Defense tech firm Anduril Industries launches a global autonomous drone racing competition, offering substantial cash prizes and guaranteed jobs to attract elite software developers to its growing Ohio operations.
At the NGA Show, industry leaders issued a stark warning: community ties alone won't save local grocers from being outpaced by tech-savvy giants and shifting consumer habits. A clear digital roadmap is now non-negotiable for survival.
Biogen (BIIB) is set to report fourth-quarter earnings before the bell Friday, with Wall Street anticipating a year-over-year revenue decline. The results come amid a mixed landscape for biotechnology peers and broader economic uncertainties.
This week's Big Tech earnings revealed a stark divide: companies using existing cash cows to fund AI ambitions versus those betting the farm on a future payoff. The market's patience for visionary spending is wearing thin, demanding concrete timelines and a path to profit.
Baidu's flagship AI assistant, Ernie, has surpassed 200 million monthly active users, a milestone reported by the Wall Street Journal. The growth underscores Baidu's deepening integration of AI across its ecosystem amid fierce competition with domestic tech rivals.
A wave of selling pressure engulfed global markets, extending beyond software stocks to hammer chipmakers and tech giants. Investor anxiety over the cost and disruptive impact of the AI arms race triggered sharp declines, with AMD and Palantir among the hardest hit, while Alphabet's massive spending plans failed to impress.
As global demand for data center capacity shows no signs of slowing, investors are scrutinizing the foundational players. We examine the strategic positions of Nvidia, Broadcom, and Micron Technology in the high-stakes race to build tomorrow's AI backbone.
Google's parent company Alphabet is set to nearly double its capital expenditure this year, committing up to $185 billion primarily for AI infrastructure, as it vies for dominance against rivals like OpenAI and Meta.
Faced with surging energy demands and local opposition, Elon Musk and other tech leaders are proposing a radical solution: building AI data centers in space. The recent merger of SpaceX and xAI marks a significant step in this cosmic ambition, as companies race to overcome earthly constraints.
As Ferrari reaffirms a key half-century technical partnership and reshuffles its F1 engineering leadership, investors in BIT:RACE are weighing these strategic moves against a backdrop of recent share price volatility and strong long-term gains.
U.S. stock futures point lower amid renewed scrutiny over AI investments, with Nvidia's landmark OpenAI deal reportedly under strain. Disney beats earnings estimates as leadership transition talks emerge, while Oracle plans a massive $50 billion raise to fuel its AI ambitions.
Oracle announces plans to raise up to $50 billion in 2026 through debt and equity to massively expand its cloud data centers, aiming to meet surging demand from AI leaders like Nvidia, OpenAI, and xAI.
Investors face a classic choice between AbbVie's steady dividends and Abivax's high-risk, high-reward potential as both target lucrative immunology markets.
Alibaba-backed Moonshot AI has unveiled an upgraded flagship model, Kimi K2.5, asserting superiority in video generation and agentic capabilities against leading U.S. models. The development coincides with Beijing's approval for major tech firms, including Alibaba, to import advanced Nvidia H200 AI chips, signaling a dual-track strategy in the intensifying global AI race.
UPS is equipping all 5,500 of its retail stores with RFID tracking, a significant expansion of its automation drive aimed at improving package visibility and reducing errors. The move highlights the company's focus on operational efficiency as it vies for higher-margin commercial clients in a competitive landscape dominated by FedEx and Amazon.
U.S. stock futures were mixed Wednesday as investors digested a flood of corporate earnings. While AMD shares tumbled on conservative guidance, all eyes are on Alphabet's report after the close for signs of AI demand strength.
As the Australian market braces for an RBA rate decision, a select group of technology and biotech firms are charting distinct paths, balancing innovation investment against shifting economic tides. We examine the prospects for Cogstate, Clinuvel Pharmaceuticals, and PYC Therapeutics.
American companies are pouring more money into AI, cybersecurity, and next-gen encryption than their international peers, yet a new report reveals widespread challenges in achieving full-scale, mature deployments.
A seismic sell-off rippled through global markets this week, erasing hundreds of billions in value from tech stocks and bonds. Unlike previous AI-driven corrections, this rout stems from a growing fear that artificial intelligence is poised to disrupt the core business models of established software giants, not just from bubble concerns.
Alphabet's robust earnings were overshadowed by a massive, above-forecast capital expenditure plan, fueling investor anxiety over bloated AI investments and sky-high valuations, triggering a sell-off across global tech and related sectors.
